Search results for "editorial"

showing 10 items of 428 documents

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

2017

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, …

0301 basic medicine030204 cardiovascular system & hematologylaw.invention0302 clinical medicinec-reactive proteinRandomized controlled triallawCardiovascular Diseasemiddle ageddouble-blind methodantibodiesMyocardial infarctionhumansStrokeinterleukin-1betabiologyAntibodies MonoclonaldrugGeneral MedicineLipidAged; anti-inflammatory agents; antibodies; monoclonal; antibodies; monoclonal; humanized; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship; drug; double-blind method; female; humans; incidence; infections; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; strokestrokeAnti-Inflammatory AgentagedEditorialfemalemyocardial infarctionAtherosclerosiMonoclonalsecondary preventionHumanmedicine.drugmedicine.medical_specialtymonoclonalNeutropeniaAntibodies Monoclonal HumanizedInfectionsPlaceboaged; anti-inflammatory agents; antibodies monoclonal; atherosclerosis; c-reactive protein; cardiovascular diseases; dose-response relationship drug; double-blind method; female; humans; incidence; infection; interleukin-1beta; lipids; male; middle aged; myocardial infarction; neutropenia; secondary prevention; stroke; medicine (all)anti-inflammatory agentsdose-response relationshiplipids03 medical and health sciencesmaleInternal medicinemedicineneutropeniamedicine (all)Dose-Response Relationship Drugbusiness.industryAntiinflammatory Therapy Canakinumab for Atherosclerotic DiseaseC-reactive proteinmedicine.diseaseinfectioncardiovascular diseasesSurgeryCanakinumab030104 developmental biologyincidencebiology.proteinatherosclerosisbusinessNew England journal of medicine
researchProduct

Functional microbiome deficits associated with ageing: chronological age-threshold

2019

Composition of the gut microbiota changes during ageing, but questions remain about whether age is also associated with deficits in microbiome function and whether these changes occur sharply or progressively. The ability to define these deficits in populations of different ages may help determine a chronological age threshold at which deficits occur and subsequently identify innovative dietary strategies for active and healthy ageing. Here, active gut microbiota and associated metabolic functions were evaluated using shotgun proteomics in three well‐defined age groups consisting of 30 healthy volunteers, namely, ten infants, ten adults and ten elderly individuals. Samples from each volunte…

0301 basic medicineAdultMaleProteomicsAgingmedia_common.quotation_subjectPhysiologyGut flora03 medical and health sciences0302 clinical medicineGut bacteriaHumansMetabolomicsMicrobiomeVolunteermedia_commonAgedbiologyMicrobiotaLongevityAge FactorsTryptophanCell BiologyChronological agebiology.organism_classificationHealthy VolunteersAgeing030104 developmental biologyEditorialAgeingIndoleChild PreschoolFemaleMicrobiome030217 neurology & neurosurgeryCohort study
researchProduct

Cellular Senescence and Inflammaging in Age-Related Diseases

2018

0301 basic medicineAgingArticle SubjectImmunologyCellular senescenceCell BiologyBiologymedicine.disease_causeBioinformatics03 medical and health sciencesOxidative Stress030104 developmental biologyEditorialAge relatedmedicinelcsh:PathologyAnimalsHumansSettore MED/05 - Patologia ClinicaCellular Senescence Inflammaging Age-Related DiseasesOxidative stressCellular Senescencelcsh:RB1-214Mediators of Inflammation
researchProduct

Harmful and Beneficial Role of ROS 2017.

2018

0301 basic medicineAgingArticle SubjectReactive oxygen species metabolismFree Radicalslcsh:CytologyMEDLINECell BiologyGeneral MedicineBiologyBioinformaticsBiochemistryAntioxidants03 medical and health sciencesOxidative Stress030104 developmental biologyEditorialAnimalslcsh:QH573-671Reactive Oxygen SpeciesIntroductory Journal ArticleSignal TransductionOxidative medicine and cellular longevity
researchProduct

Estrogenic regulation of skeletal muscle proteome : a study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy

2017

Female middle age is characterized by a decline in skeletal muscle mass and performance, predisposing women to sarcopenia, functional limitations, and metabolic dysfunction as they age. Menopausal loss of ovarian function leading to low circulating level of 17b-estradiol has been suggested as a contributing factor to aging-related muscle deterioration. However, the underlying molecular mechanisms remain largely unknown and thus far androgens have been considered as a major anabolic hormone for skeletal muscle. We utilized muscle samples from 24 pre- and postmenopausal women to establish proteome-wide profiles, associated with the difference in age (30–34 years old vs. 54– 62 years old), men…

0301 basic medicineAgingnaisetlabel‐free protein quantitationProteomeAnabolismvaihdevuodetmedicine.medical_treatmentTwinsmenopausenano‐LC‐HD‐MSElihakset0302 clinical medicineSTRENGTHBRAIN315 Sport and fitness sciencesta315luustoINHIBITORHormone replacement therapy (menopause)ta3142MITOCHONDRIAL BIOGENESISMiddle AgedPostmenopauseMenopauseREPLACEMENThormone replacement therapyEditorialmedicine.anatomical_structurehormonihoitoHormonal therapyOriginal ArticleFemalemuscleswomenAdultestrogeenitnano-LC-HD-MSEEXPRESSIONmedicine.medical_specialtyBiologyestrogenic regulation03 medical and health sciencesmitochondrial functionInternal medicinemedicineHumansMuscle Skeletallabel-free protein quantitationmuscle proteomeAgedSkeletal muscleEstrogenslabel-free proteinquantitationOriginal ArticlesCell Biologyfunctional annotationmedicine.diseaseMiddle ageMONOZYGOTIC TWIN PAIRS030104 developmental biologyEndocrinologyPremenopauselihasmassaSarcopeniaCELLS3111 BiomedicineEnergy Metabolismfemale muscle030217 neurology & neurosurgeryskeletal musclesHormone
researchProduct

Editorial for Special Issue “Bioactive Oxadiazoles”

2021

Oxadiazoles are electron-poor, five-membered aromatic heterocycles containing one oxygen and two nitrogen atoms [...]

0301 basic medicineAnti-Inflammatory AgentsCatalysislcsh:ChemistryInorganic Chemistry03 medical and health sciences0302 clinical medicineIsomerismCoordination ComplexesOrganic chemistryCyclooxygenase InhibitorsPhysical and Theoretical Chemistrylcsh:QH301-705.5Molecular BiologySpectroscopyOxadiazolesChemistryOrganic ChemistryGeneral MedicineComputer Science ApplicationsEditorialn/a030104 developmental biologylcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisIntroductory Journal ArticleInternational Journal of Molecular Sciences
researchProduct

The Interplay between Metabolism, PPAR Signaling Pathway, and Cancer

2017

0301 basic medicineArticle SubjectCancerMetabolismBiologymedicine.diseasePPAR signaling pathway03 medical and health sciences030104 developmental biology0302 clinical medicineEditoriallcsh:Biology (General)030220 oncology & carcinogenesisDrug DiscoverymedicineCancer researchPharmacology (medical)lcsh:QH301-705.5PPAR Research
researchProduct

Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018

2018

0301 basic medicineArticle SubjectTraditional medicinelcsh:Other systems of medicineBiologylcsh:RZ201-999medicine.diseaseMetabolism disorder03 medical and health sciencesEditorial030104 developmental biologyComplementary and alternative medicineDiabetes mellitusmedicineMedicinal plantsEvidence-Based Complementary and Alternative Medicine
researchProduct

Dual Function Molecules and Processes in Cell Fate Decision: A Preface to the Special Issue

2020

A lot of water has passed under the bridge since 1999, when C.J. Jeffery stated in a pioneering review that “the idea of one gene-one protein-one function has become too simple” [...]

0301 basic medicineBiologyCatalysisInorganic Chemistrylcsh:Chemistry03 medical and health sciences0302 clinical medicineSettore BIO/10 - BiochimicaAnimalsHumanscell fate decisionPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyDual functiondouble-faced molecules and processesOrganic ChemistryGene Expression Regulation DevelopmentalCell DifferentiationGeneral MedicineComputer Science Applications030104 developmental biologyEditorialn/alcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisNeuroscienceSignal TransductionInternational Journal of Molecular Sciences
researchProduct

Direct and Inverse Comorbidities Between Complex Disorders

2016

Comorbidity and multimorbidity, defined as the presence of more than one disease in individuals, have emerged as a major challenge in the last decade (Valderas et al., 2009). Indeed, researchers, health professionals, healthcare managers and policy makers, and patients and citizens are lagging behind considering the comorbidity scenario, as illustrated by the paucity of documentation concerning interventions in people with multiple conditions (Smith et al., 2012). There is a clear need to better understand disease-disease relationships, in order to better organize and provide care, but also to develop appropriate research models. We can first characterize direct multimorbidity (higher-than-…

0301 basic medicineBiopsychosocial modelNosologymedicine.medical_specialtymedicinemultimorbidityPhysiologymalaltiesContext (language use)Disease03 medical and health sciencesPhysiology (medical)MultimorbidityMedicinecomplex diseasesPsychiatryOMICS dataComputingMilieux_MISCELLANEOUSbusiness.industrymedicine.diseaseComorbidity[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]3. Good healthcomorbidityEditorial030104 developmental biologyAge of onsetbusinessNeurocognitive
researchProduct